Combination therapy with daily interferon alpha and ribavirin in naive patients with chronic hepatitis C.

被引:0
|
作者
Rothstein, KD [1 ]
Suvannasankha, A [1 ]
Digreggorio, K [1 ]
Gross, F [1 ]
Peikin, S [1 ]
Mushnick, A [1 ]
Deangelo, C [1 ]
Salowe, D [1 ]
Siegel, H [1 ]
Shaw, E [1 ]
Bond, K [1 ]
Manzarbeitia, C [1 ]
机构
[1] Albert Einstein Med Ctr, Philadelphia, PA 19141 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1836
引用
收藏
页码:619A / 619A
页数:1
相关论文
共 50 条
  • [21] Daily interferon alpha-2B and ribavirin combination therapy for liver transplant patients with chronic hepatitis C infection
    Beckebaum, S
    Cicinnati, VR
    Karliova, M
    Dirsch, O
    Erim, Y
    Frilling, A
    Malago, M
    Broelsch, CE
    Treichel, U
    Gerken, G
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (06) : 2080 - 2081
  • [22] Alpha interferon and ribavirin combination therapy of chronic hepatitis D
    Kaymakoglu, S
    Karaca, C
    Demir, K
    Poturoglu, S
    Danalioglu, A
    Badur, S
    Bozaci, M
    Besisik, F
    Cakaloglu, Y
    Okten, A
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (03) : 1135 - 1138
  • [23] Interferon/ribavirin combination therapy with and without daily dosing in retreatment of chronic hepatitis C
    Bernatik, T
    Klinker, H
    Scheurlen, M
    Meyer, H
    Norgauer, W
    Rambach, W
    Sapper, U
    Hahn, EG
    Schuppan, D
    Schneider, HT
    JOURNAL OF HEPATOLOGY, 2000, 32 : 187 - 187
  • [24] Daily combination therapy in treatment naive and previous nonresponders with chronic hepatitis C.
    Lawitz, EJ
    Nader, P
    Cox, J
    Diamond, K
    Ganeshappa, KP
    Reddy, G
    Lindner, M
    Nguyen, T
    Vemuru, R
    Cantu, NS
    HEPATOLOGY, 2002, 36 (04) : 580A - 580A
  • [25] Interferon/ribavirin combination therapy with and without daily dosing in retreatment of chronic hepatitis C
    Frieser, MH
    Bernatik, T
    Klinker, H
    Scheurlen, M
    Meyer, H
    Norgauer, W
    Rambach, W
    Meier, K
    Hahn, E
    Schuppan, D
    Schneider, HT
    JOURNAL OF HEPATOLOGY, 2001, 34 : 152 - 152
  • [26] Changes in lipid profile during combination therapy with alpha-interferon and ribavirin in patients with chronic hepatitis C. Is there a correlation with response to therapy?
    Kazemi-Shirazi, L
    Hofer, H
    Vukovich, P
    Kostner, K
    Gangl, A
    Ferenci, P
    GASTROENTEROLOGY, 2000, 118 (04) : A1456 - A1456
  • [27] Combination therapy with ribavirin plus alpha-interferon for the treatment of chronic hepatitis C in naive patients and use of Beck Depression Inventory
    Kwo, PY
    Fields, S
    Chalasani, N
    Cho, W
    Crabb, DW
    Cummings, OW
    Imperiale, T
    Krause, AK
    Lumeng, L
    McGill, JM
    Ness, R
    Callon, R
    Pintozzi, R
    Jones, B
    Lansford, C
    Pappas, SC
    Rusche, HF
    Maier, J
    Isenberg, M
    Van Dyke, V
    GASTROENTEROLOGY, 1999, 116 (04) : A1235 - A1235
  • [28] A multi-center randomized trial comparing daily induction dose interferon alpha 2b plus ribavirin followed by daily combination therapy versus standard combination therapy in treatment naive patients with chronic hepatitis C.
    Lawitz, EJ
    Kadakia, SC
    Cantu, NS
    Jeffries, MA
    Schutz, SM
    Sheinbaum, A
    Torivara, N
    Jolley, JJ
    Matossian, H
    Moulis, H
    Glombicki, AP
    Galen, E
    HEPATOLOGY, 2000, 32 (04) : 556A - 556A
  • [29] A comparison of standard and induction interferon therapy with and without initial ribavirin in treatment naive patients with chronic hepatitis C.
    Peine, CJ
    Albrecht, JK
    Roel, JP
    Gundersen, BA
    Kirchner, JP
    Zins, B
    McKee, D
    Ho, SB
    Smith, T
    HEPATOLOGY, 2000, 32 (04) : 364A - 364A
  • [30] COMBINATION THERAPY WITH RIBAVIRIN AND ALPHA-INTERFERON IN PATIENTS WITH CHRONIC HEPATITIS-C RESISTANT TO ALPHA-INTERFERON TREATMENT
    BRILLANTI, S
    MASCI, C
    MIGLIOLI, M
    BARBARA, L
    HEPATOLOGY, 1993, 18 (04) : A150 - A150